Ocular Sealants and Glues Market

By Product Type;

Adhesive Sealants, Biodegradable Sealants, Nonbiodegradable Glue, Conductive Sealants, and Thermal Protection Sealants

By Application;

Conjuctival Surgery, Tissue Engineering, Refractive Surgery, Corneal Surgery, and Vitreo Retinal Surgery

By End-User;

Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Care Centers

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn609347717 Published Date: June, 2025 Updated Date: August, 2025

Ocular Sealants and Glues Market Overview

Ocular Sealants and Glues Market (USD Million)

Ocular Sealants and Glues Market was valued at USD 166.06 million in the year 2024. The size of this market is expected to increase to USD 270.17 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.2%.


Ocular Sealants and Glues Market

*Market size in USD million

CAGR 7.2 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.2 %
Market Size (2024)USD 166.06 Million
Market Size (2031)USD 270.17 Million
Market ConcentrationMedium
Report Pages312
166.06
2024
270.17
2031

Major Players

  • Ocular Therapeutix Inc
  • Johnson & Johnson
  • Reliance Life-Sciences
  • Hyperbranch Medical Technology Inc
  • Concord Drugs Limited
  • Connexicon Medical Ltd
  • Medline Industries
  • CSL Behring Gmbh
  • Thermogenesis Corp
  • Baxter Ag

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Ocular Sealants and Glues Market

Fragmented - Highly competitive market without dominant players


The Ocular Sealants and Glues Market is rapidly advancing due to increasing demand for minimally invasive eye surgeries and breakthroughs in bioadhesive formulations. These products are emerging as a preferred alternative to sutures, offering enhanced wound closure, faster healing, and lower complication risks. Their use in cataract, retinal, and corneal procedures has grown significantly, contributing to market traction.

Key Growth Drivers Accelerating Adoption
A rising volume of ophthalmic surgeries and an aging population have pushed the market growth to over 8%. Surgeons increasingly favor these glues for their biocompatibility and ability to reduce inflammation and post-surgical discomfort. These adhesives also help maintain ocular integrity during complex interventions, making them integral to modern surgical protocols.

Technological Innovation Enhances Performance
Next-gen sealants featuring synthetic polymers and fibrin compounds now deliver stronger adhesion and greater flexibility. Improvements in application techniques and cross-linking agents have led to better usability and procedural outcomes. These innovations have supported market expansion by more than 7%, reinforcing their clinical reliability.

Improved Outcomes and Clinical Efficiency
By reducing leakage, infection, and trauma, ocular glues are delivering safer outcomes and shortening patient recovery times. Their ability to create watertight seals has led to their integration in routine practice, with over 65% of surgeons reporting better surgical efficiency and fewer post-op complications when using these products.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By End-User
    4. Market Snapshot, By Region
  4. Ocular Sealants and Glues Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Number of Ophthalmic Surgeries
        2. Advancements in Technology and Materials
        3. Growing Aging Population
        4. Expanding Healthcare Access in Emerging Markets
      2. Restraints
        1. High Cost of Advanced Products
        2. Stringent Regulatory Requirements
        3. Limited Awareness in Developing Regions
        4. Risk of Adverse Reactions
      3. Opportunities
        1. Expansion into Emerging Markets
        2. Development of Cost-Effective Products
        3. Integration with Minimally Invasive Techniques
        4. Strategic Collaborations and Partnerships
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Ocular Sealants and Glues Market, By Product Type, 2021 - 2031 (USD Million)

      1. Adhesive Sealants

      2. Biodegradable Sealants

      3. Nonbiodegradable Glue

      4. Conductive Sealants

      5. Thermal Protection Sealants

    2. Ocular Sealants and Glues Market, By Application, 2021 - 2031 (USD Million)
      1. Conjuctival Surgery
      2. Tissue Engineering
      3. Refractive Surgery
      4. Corneal Surgery
      5. Vitreo Retinal Surgery
    3. Ocular Sealants and Glues Market, By End-User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ophthalmic Clinics
      3. Ambulatory Surgical Care Centers
    4. Ocular Sealants and Glues Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Ocular Therapeutix Inc
      2. Johnson & Johnson
      3. Reliance Life-Sciences
      4. Hyperbranch Medical Technology Inc
      5. Concord Drugs Limited
      6. Connexicon Medical Ltd
      7. Medline Industries
      8. CSL Behring Gmbh
      9. Thermogenesis Corp
      10. Baxter Ag
  7. Analyst Views
  8. Future Outlook of the Market